Skip to main content

Table 2 Cohort characteristics

From: Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database study

Variable

Person-Years

Percent

Age group

 19–49 years

35,360,219.65

61.92

 50–64 years

21,748,096.07

38.08

Gender

 Female

27,290,491.17

47.79

 Male

29,817,824.55

52.21

Health plan type

 Fee-for-service

1,159,288.49

2.03

 PPO/EPO

36,123,603.49

63.25

 HMO

6,943,639.48

12.16

 POS

4,046,790.82

7.09

 HDHP/CDHP

6,592,500.88

11.54

 Unknown

2,242,492.56

3.93

Medical conditions

 Healthy

47,370,548.67

82.95

 With at-risk or high-risk conditions

9,737,767.05

17.05

At-risk conditions

 Overall

7,119,125.33

100.0

 Asthma

1,596,160.50

22.42

 Chronic heart disease

1,432,517.29

20.12

 Chronic lung disease

1,007,145.18

14.15

 Chronic liver disease

607,949.48

8.54

 Diabetes mellitus

3,656,304.75

51.36

Number of at-risk conditions

 1

6,089,016.03

85.53

  ≥ 2

1,030,109.30

14.48

High-risk conditions

 Overall

2,618,641.72

100.0

 Chronic renal disease

424,677.27

16.22

 Cancer

1,825,298.26

69.70

 Asplenia

40,691.59

1.55

 HIV

108,115.60

4.13

 Organ transplant

522,834.47

19.97

Number of high-risk conditions

 1

2,325,408.37

88.80

  ≥ 2

293,233.35

11.19

Number of years in follow-up period

 Mean (SD)

0.93 (0.20)

 
  1. HDHP/CDHP High Deductible/Consumer Driven Health Plan, HIV human immunodeficiency virus, HMO Health Maintenance Organization, POS Point of Service, PPO/EPO Preferred/Exclusive Provider Organization, SD standard deviation